Variable Impact on Mortality of AIDS‐Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS‐Defining Conditions Are Created Equal
Open Access
- 15 April 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (8) , 1138-1151
- https://doi.org/10.1086/597468
Abstract
Background. The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)-defining events (ADEs) has not beenKeywords
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA Randomized TrialPublished by American Medical Association (AMA) ,2004
- Combination Antiretroviral Therapy and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2003
- Composite Outcomes in Randomized TrialsJAMA, 2003
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral TherapyAnnals of Internal Medicine, 1991
- The AIDS-defining diagnosis and subsequent complications: a survival-based severity index.1991
- Leads from the MMWR. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome.1987
- Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.1985
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981
- KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASESThe Lancet, 1981